Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accumulated Expenses (2016 - 2025)

iBio (IBIO) has disclosed Accumulated Expenses for 15 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 13.95% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 13.95% year-over-year, with the annual reading at $1.3 million for FY2025, 33.68% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $1.6 million at iBio, up from $850000.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $5.0 million in Q4 2022, with the low at $850000.0 in Q3 2025.
  • Average Accumulated Expenses over 5 years is $2.7 million, with a median of $2.7 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses soared 134.89% in 2021, then crashed 68.24% in 2024.
  • Over 5 years, Accumulated Expenses stood at $2.8 million in 2021, then soared by 75.97% to $5.0 million in 2022, then decreased by 24.88% to $3.8 million in 2023, then crashed by 51.16% to $1.8 million in 2024, then decreased by 13.95% to $1.6 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $1.6 million, $850000.0, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.